Women's Health Flashcards

(399 cards)

1
Q

Epidemiology of subfertility/infertility

A

1 in 7 women
50% are due to females
25% due to males
25% are unknown

Increases with age
No family history

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Risk factors for subfertility/infertility

A
Increasing female age
Depression
Stress
STIs
Smoking
Alcohol intake (even moderate)
Overweight or underweight
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Causes of infertility (general)

A
25% ovulatory
20% tubular damage
10% uterine or peritoneal disorders
30% male
25% unknown
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are the 3 WHO classifications for disorders of ovulation

A

Group 1 - hypothalamic-pituitary failure (low oestrogen, low gonadatrophin)

Group 2 - hypothalamic-pituitary-ovarian failure (normal oestrogen, high or low gonadatrophin)

Group 3 - ovarian failure (raised gonadatrophin, low oestrogen)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Causes of ovulatory dysfunction causing infertility

A

PCOS

  • Pituitary tumours
  • Panhypopituitarism (Simmond’s disease)
  • Sheehan’s disease (pituitary infarction following PPH)
  • Hyperprolactinaemia
  • Chromosomal disorders (Turners XO, Klinefelter’s XXY) XXX (increased premature ovarian failure)
  • Premature ovarian failure/ menopause
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Role of FSH

A

Follicle stimulating hormone

Stimulates follicle development and oestrogen production

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Role of LH

A

Midcycle LH surge causes ovulation.

Maintains corpus luteum and stimulates progesterone and estradiol production

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Causes of infertility - tubes/uterus/cervix

A
STI (PID from chlamydia or gonorrhoea)
Asherman's syndrome (adhesions in uterus and cervix)
Deformity of uterus
Fibroids
Cervical mucus
Endometriosis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What drugs can lead to sub/infertility?

A
Phenothiazines (antipsychotics)
Metoclopramide
NSAIDs
Immunosuppressants
Spironolactone
Chemotherapy
Neuroleptic drugs
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Causes of infertility - male

A

Structural or hormonal

  • Genetic (Klinefelters XXY), Kallman syndrome (hypogonatrophic hypogonadism)
  • Androgen insensitivity
  • Cryptorchidism (testicular dysgenesis)
  • Varicocoele
  • Pituitary causes (tumours)
  • Testicular tumours
  • Severe hyperprolactinaemia
  • Obstruction
  • Erectile dysfunction
  • Hypospadias
  • Retrograde ejaculation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Advice for couple trying to conceive

A

Regular sexual intercourse (2-3x per week)
Preparation for pregnancy (folic acid, rubella check, cervical screening)
Decrease stresses
Smoking and alcohol cessation
BMI between 19 and 25

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Investigations for sub/infertility

A

Start if not conceived in 1 year

FEMALE

  • Measure mid-luteal progesterone day 21 of 28 (7 days before period
  • If irregular cycles measure FH and LSH
  • Test thyroid function
  • Measure prolactin
  • Screen for chlamydia and other STIs

MALE
- Semen analysis
- Screen for STIs
Semen sample should be collected after at least 2 days but less than 7 from sexual abstinence

After referral

  • Tubal patency (hysterosalpinography or contrast ultrasonography) HSG
  • If co-morbidities the lap and dye testing
  • Ovarian reserve testing - on day 3 to predict response to stimulation in IVF

Males - further sperm assessment - microbiology, culture
Imaging of tracts

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

When should sub/infertility be referred

A

Follow local guidelines

  • Under 36 refer after 1 year

Consider early referral if

  • over 36 (6 months)
  • known cause for infertility
  • history of factors that predispose to infertility
  • treatment planned that may result in infertility (chemotherapy)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Management of subfertility/infertility

A

Treat underlying problem

  • Ovulation induction with Clomifene
  • Gonadatrophins if clomifene resistant (pulsatile)
  • If male obstruction, correct surgically
  • Surgical correction of tubes
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Different types of assisted conception

A
Intrauterine insemination
In vitro fertilisation
Intracytoplasmic sperm injection (ICSI)
Donor insemination
Oocyte donation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Describe intrauterine insemination

A

15% success in under 35s
Prepared sperm placed into uterine cavity at ovulation (induced or spontaneous)

Used when

  • difficult to have intercourse (unable, disability, psychological)
  • HIV+ male (sperm washing)
  • Same sex relationships
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Describe IVF

A

33% success in under 35s
25% of treatments result in live births

Offered after 2 years

  • Ovarian stimulation prior to IVF with US measured response
  • Embyro inserted into uterus
  • Progesterone given after embryo for luteal phase support
  • transfer single embryo

Under 40s up to 3 cycles - stop once reach 40
Over 40s, 1 cycle if never had IVG, no evidence of low ovarian reserve

Some CCGs in addition
- No previous children, or partner with any children, healthy weight, non-smoker

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Describe Intracytoplasmic sperm injection (ICSI)

A

Single sperm injected into oocyte

Used when severe deficits in sperm or after failed IVF

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

When can donor insemination be used

A

Azoospermia
Severe deficits in sperm quality and don’t want ICSI
High risk of transmitting genetic disorder
High risk of transmitting infectious disease to child/partner

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Complications of assisted conception

A

OVARIAN HYPERSTIMULATION SYNDROME (OHSS)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Symptoms of ovarian Hyperstimulation syndrome

A
lower abdo discomfort
nausea and vomiting
diarrhoea
abdo distension
ascites
rapid weight gain
tachycardia
hypotension
oliguria
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

What factors should be considered when prescribing contraception?

A
Womens preference and choice
Education - must be fully informed
Co-morbidities
Medications
Age and parity
Smoking history
Weight
Family plans (long vs short term)
Protection from STIs
Exclude pregnancy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

MOA of COCP

A

Prevents conception by acting on hypothalamic-pituitary-ovarian axis to suppress synthesis and secretion of FSH and LH

Inhibits development of ovarian follicles and ovulation
Cervical mucus to prevent sperm penetration
Endometrium to inhibit blastocyst secretion of LH and LSH

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Advantages and disadvantages of COCP

A

Advantages:
Non invasive
Regular and lighter periods, decrease pain
Control time of periods
Can improve acne
Decreases ovarian, endometrial and colorectal cancer
Decrease PMS symptoms

Disadvantages:
User dependent
Less effective than long acting
Side effects
VTE risk
No protection from STIs
Breakthrough bleeding in first few months
Increased breast and cervical cancer
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
When prescribing contraception - what criteria should be checked?
``` UKMEC - UK Medical Eligibility Criteria 1 - no restriction for use 2 - advantages > disadvantages 3 - risks outweigh advantage - not recommended 4 - use is unacceptable ```
26
What questions must be asked before prescribing COCP Advice to give
``` Migraine Smoker HTN Thrombophilia Previous VTE FHx of VTE Hyperlipidaemia BP BMI Exclude pregnancy ``` Start on first day of bleeding (or within 5 days) Drug interactions D&V advice - use alterative protection Need alternative protection for first 7 days
27
MOA of progestogen only pill POP
Ovulation is inhibited by varying degrees depending on the drug Delays transport of ovum Cervical mucus thickens Endometrium becomes unsuitable for implantation
28
Advantages and disadvantages of POP
``` A Non invasive Easily reversible Avoids CV risk of COCP Less restriction Can be used up to 55 and while breastfeeding ``` D - Amennorhoea and breakthrough bleeds - narrower window - increase risk of cysts - increased risk of ectopic pregnancy if become pregnant - Irregular periods
29
Describe depot progesterone injections and MOA
Every 12 weeks Long acting reversible progesterone only Failure rate 2 in 1000 Thickens mucus Endometrium unsuitable for implantation Can be used 4 weeks post partum
30
Advantages and disadvantages of POP
A - Reliable - Infrequent - Low risk - Low failure rate - Decreases bleeding - Used in breast feeding D - not quickly reversible - Decrease bone mineral density - irregular periods - weight gain (up to 3kg)
31
Describe Implanon/implants
Etonogestrel subdermal slow release in upper arm Failure rate < 1 in 1000 Inhibits ovulation , thickens mucus, thins endometrium Inserted with local anaesthetic Can be given 21 days post partum Can be given straight after termination
32
Advantages and disadvantages of Implants
A - No large initial dose or fluctuations - Low failure rate - Reversible after 4 days - Decreased menstrual problems - Safe D - irregular bleeding - weight, mood and libido changes - Changes with bleeding DO NOT SETTLE WITH TIME - Increases risk of congenital malformation
33
Describe IUD
Copper containing Long acting Reversible T shape, sits in fundus of uterus Cytotoxic - inflammatory reaction and is spermicidal Very low failure rate 5-10 years lifespan
34
Advantages and disadvantages of IUD
A - Effective, reversible - Long acting (up to 10 years) - Can be used as emergency contraception - No hormones D - Spotting - Increased bleeding and pain in first few cycles - Perforation 0.2% - Increased ectopic pregnancy - Uncomfortable insertion
35
Describe IUS
Progesterone releasing Decreased endometrial growth, thickens mucus
36
Advantages and disadvantages of IUS
A - effective, convenient - reversible - decreased blood loss and dysmenorrhoea - decrease risk of PID - local action only D - common - irregular periods - increase ovarian cysts - increased ectopic pregnancy - expulsion or perforation
37
Side effects of progesterone
acne breast tenderness headache mood changes
38
Describe caps and diaphragms
Rarely used High failure rate Diaphragms - thin dome 55-100mm. Lie between posterior fornix and pubic bone Caps are smaller and fit over cervix, held by suction Only used if problem with diaphragm Often used with spermicide
39
Effectiveness of female barrier contraception
Percentage to conceive 16% - diaphragm 32% parous with cap 16% cap in nulliparous 21% female condom
40
Describe natural planning and A&D
Calendar methods/temperature/mucus thickness/palpating cervix A - no side effects. complies with religious beliefs D - commitment. unreliable. not effective
41
Steps in fertilisation
12-24 hours after ovulation Sperm enter vagina and swim to uterus Prostaglandin in semen stimulate uterine contractility CAPACITATION (increase speed of sperm tail wiggle, removal of proteins/coatings) Acrosomal enzymes aid penetration of corona radiata and zona pellucida ZP3 in zona pellucida acts as sperm receptor and depolarises cell once in contact to prevent polyspermy
42
Procedure of termination
Offer antibiotic prophylaxis as 10% get genital tract infection (metronidazole +/- doxycycline or arythromycin) Surgical - Less than 14 weeks, vacuum aspiration + vaginal misoprostol 3 hours prior - 14-24 weeks, dilation and evacuation - Under sedation, local or general Medical - 200mg oral mifepristone followed by misoprostol - NSAID for pain relief
43
Complications of termination
``` Infection (10%) Cervical trauma - surgical only Failed termination <1% Haemorrhage Perforation - surgical Long term psychological consequences ```
44
What is cryopreservation?
Freezing of gametes to preserve fertility Availability if undergoing treatment that may affect fertility like chemotherapy If - will not worsen their condition - enough time is available before the start of treatment
45
what is PCOS
polcystic ovarian syndrome syndrome of polcystic ovaries AND systemic symptoms causing reproductive, metabolic and psychological disturbance infertility, amenorrhoea, acne and hirsuitism
46
epidemiology of PCOS
33% of women have polcystic ovaries but not the syndrome affects 5-10% of reproductive age women pre menopausal women onset at age of menarche
47
pathophysiology of PCOS
unknown but is multifactorial excess androgen so by theca cells of ovary insulin resistance raised LH due to increased production raised oestrogen genetic link but no gene found
48
symptoms of PCOS
``` oligomenorrhoea infertility or subjectivity acne hirsuitism alopecia obesity psychological- mood swings, depression, anxiety sleep apnoea ```
49
signs of PCOS
hirsuitism alopecia central obesity acanthosis nigricans (hyperpigmented skin in folds) rarely - increased muscle mass, deep voice
50
what are the diagnostic criteria for PCOS
2 out of 3 - polcystic ovaries on US. 12+ peripheral follicles or increased ovarian volume >10cm3 - oligo ovulation or anovulation - clinical and/or biochemical signs of hyperandrogenism
51
investigations for PCOS
total testosterone - normal or slightly raised free testosterone- may be raised Sex hormone binding globulin - normal or low free androgen index- normal or raised LH - typically raised LH: FSH >2 with normal FSH ultrasound. cysts. raised volume also consider: TFTs, prolactin, cortisol fasting glucose and lipids
52
management of PCOS
advice on weight control if not planning pregnancy - co-cyprinolol for hirsuitism and acne. induces regular bleeds to decrease endometrial cancer - COCP: for menstrual irregularity - metformin - eflornithine for hirsuitism - orlistat for weight loss ``` if planning pregnancy - clomifene - metformin one of both - laparoscopic ovarian drilling or gonadotrophins (if clomifene resistant) ```
53
complications of PCOS
``` infertility amenorrhoea increased CV risk sleep apnoea increased type 2 or gestational diabetes increased pre term birth or pre eclampsia ```
54
In Down's screening what is tested in a quadruple test?
Beta-hcg AFP (alpha fetoprotein) Inhibin A UE3 (unconjugated estriol)
55
What are the results of serum markers if a baby has Down's?
``` PAPP-A - lower in Down's beta-hcg - raised in Down's AFP - lower in Down's UE3 - lower in Down's Inhibin A - raised in Down's ```
56
What factors can affect Down's screening?
``` Weight Race IVF Diabetes Smokers Twins ```
57
Describe nuchal scanning in Downs
- Performed between 11 and 14 weeks - Measure nuchal pad at nape of neck - Increased nuchal translucency = higher change of chromosomal abnormality - 20% false positive rate
58
Describe amniocentesis
- Sample of amniotic fluid to examine foetal cells - Done between 12-18 weeks - Chromosomal, genetic and biochemical analysis - Management of rhesus disease - Estimation of maturity Indicated if: - Mother over 35 - Previous child with chromosomal abnormality - + antenatal screening Procedure - give rhesus prophylaxis where needed - US guided, 22 gauge spinal needle through abdo wall into uterus 10-20ml aspirated 7% loss of pregnancy is done 12-14 weeks
59
Describe chorionic villus sampling
Sampling of developing plancenta late in the first trimester to allow examination of foetal karyotype/genotype - Done transabdominally Indicated if: - advanced maternal age - PHx of chromosomal/genetic abnormality Procedure - between 11 and 13 weeks - US guided needle aspiration First trimester, 2% miscarry, 2nd trimester 3%
60
What information should be provided during antenatal care?
FIRST CONTACT - folic acid supplementation - lifestyle advice - smoking, drugs, alcohol - food hygiene - information on all antenatal screening AT BOOKING - nutrition and diet - place of birth - exercises - pregnancy care pathway - discuss mental health issues BEFORE or AT 36 weeks - breastfeeding information - preparation for labour and birth - recognising active labour - care of the new baby - vitamin K prophylaxis
61
Lifestyle advice to be given in pregnancy
Folic acid 400 micrograms/day ideally before conception Avoid vitamin A (teratogenic) Vitamin D supplementation if darker skin or low Avoid unpasteurised milk, soft cheese, pate (listeriosis) Avoid salmonella risk - no raw or partially cooked eggs Seatbelt placed above and below bump
62
What screening is done Antenatally?
Anaemia - booking, 28 weeks Blood grouping - blood group and rhesus D status Haemoglobinopathies Foetal anomalies - 18-20 weeks US scan Infection - MSU early pregnancy, BV, chlamydia, hep B, HIV, syphilis, rubella Placenta praevia
63
How is foetal growth monitored?
Symphysis-fundal height from 24 weeks
64
Management of breech baby at 36 weeks?
external cephalic version
65
Management of pregnancy over 41 weeks
- Vaginal exam plus membrane sweeping - Induction offered after 41 weeks - if declined, twice weekly cardiotocography
66
At what weeks are antenatal appointments offered?
``` 10 weeks 16 weeks 18-20 weeks - US scan NP - 25 weeks (start symphysis-fundal height) 28 weeks - antiD NP - 31 weeks 34 weeks - 2nd dose antiD 36 weeks 38 weeks NP - 40 weeks 41 weeks - for induction ``` All appointments - BP and proteinuria
67
Definition of miscarriage
Loss of pregnancy before 24 weeks of gestation.
68
Types of miscarriage
Threatened - mild bleeding, little or no pain. Cervical os closed. Ongoing pregnancy Inevitable - heavy bleeding + clots and pain. Cervical os is open. Pregnancy will not continue Incomplete - products of conception partially expelled Missed/silent - foetus is dead but retained. uterus small for dates. Habitual/recurrent - 3+ consecutive miscarriages Septic - complication of incomplete or therapeutic abortion when intrauterine infection occurs
69
Epidemiology and risk factors for miscarriage
Increases with age 10-15% of pregnancies 85% in the first trimester RFs - increased number of births (parity) - Smoking - Excess alcohol - Illicit drug use - Uterine surgery or abnormalities e.g. incomplete cervix - Connective tissue disorders (SLE, APLS) - uncontrolled diabetes
70
Aetiology of miscarriage
Often no cause found - Abnormal foetal development - abnormal chromosomes - Genetically balanced parental translocation - Placenta failure - uterine abnormality - bicornuate, fibroids - Incompetent cervix (2nd trimester) - Multiple pregnancy - Autoimmune - SLE, APLS - PCOS 50% unexplained
71
Presentation of miscarriage
Vaginal bleeding (heavier bleeding = increased risk) Abdominal pain Passed products of conception/clots 50% with threatened miscarriage will later miscarry - Open cervical os - Uterine size not appropriate for dates - Products of conception in cervical canal
72
Investigations for miscarriage
US - TV, if there is no visible heart beat, a 2nd scan should be done in 7-14 days depending on size of sac Serum hcg - levels below 1000 in pregnancy of unknown location or complete miscarriage
73
Management of miscarriage
Support, follow up and counselling Anti-D to all rhesus negative CONSERVATIVE - Expectant, should resolve naturally 7-14 days - Consider other management if: risk of haemorrhage, late in first trimester, previous adverse miscarriage outcome, infection, coagulopathies - Pregnancy test 3 weeks after - if still positive, medical or surgical management MEDICAL - Vaginal misoprostol, analgesia and anti-emetics - Causes more pain and bleeding than surgical - Pregnancy test 3 weeks after SURGICAL - If persistent bleeding, haemodynamic instability, retained tissue, gestationaltrophoblastic disease - Manual vacuum aspiration under local or surgical under GA - Complications: perforation, cervical tears, adhesions, haemorrhages - Screen for chlamydia
74
Types of gestational trophoblastic disease
Can be pre-malignant or malignant - due to abnormal proliferation of trophoblastic tissue. Pre-malignant - Complete hydratiform mole - Partial hydratiform mole Malignant - Invasive mole - Choriocarcinoma - Placental site trophoblastic disease - Epitheliod trophoblastic disease
75
Describe complete molar pregnancies
All genetic material comes from the father when an empty oocyte is fertilised - No foetal tissue - 46 XX karyotype - Placental tissue has marked hyperplasia and gross swelling of villi - "bunch of grapes" appearance - 10-15% become malignant, very sensitive to chemo - No embryo
76
Describe partial molar pregnancy
- 3 sets of chromosomes - 2 sperm fertilise at the same time - 69 chromosomes, 46 paternal, 23 maternal - embryo visible on early US - usually diagnosed on histology after miscarriage - <1% malignancy
77
Describe complete mole
- Develops form a complete molar pregnancy - Invades into myometrium - Uterine mass with elevated hCG - Responds well to chemo
78
Describe choriocarcinoma
Synctiotrophoblasts - Often follows a molar pregnancy but can be post normal pregnancy, ectopic or abortion - continued vaginal bleeding post-pregnancy - Often metastasises - lung, brain, GI, liver, kidney - Can occur up to 20 years post pregnancy
79
Epidemiology and risk factors for gestational trophoblastic disease
GTD - 1 in 714 births Complete molar pregnancy - 1-3 per 1000 pregnancies Partial - 1 per 1000 GTN - 1 in 50,000 live births RFs - over 45 or under 16 - previous molar pregnancy - multiple pregnancy - menarche over 12, light menstruation - COCP of history of use - Asian
80
Presentation of GTD
Vaginal bleeding in first trimester Hyperemesis Rare - abnormal uterine enlargement - hyperthyroidism - anaemia - respiratory distress - pre-eclampsia
81
Investigations for GTD
- hCG (best for follow up) - Histology for definitive diagnosis (should be done for all products of conception - US: snowstorm appearance in 2nd trimester, heterogenous mass, no foetal development - CT if staging for metastatic disease
82
Management of GTD
Refer for follow up at a trophoblastic screening centre - Suction curettage - Uterine pregnancy test at 3 weeks - Anti D prophylaxis - SENIOR SURGEON Follow up - 2 weekly until hCG normal - monthly for 6 months after Chemotherapy - if choriocarcinoma, mets, heavy bleeding, plateaued or rising hCG - LOW risk: methotrexate & calcium folinate - HIGH risk: EMA/CO chemotherapy combination
83
Epidemiology and RF for ectopic pregnancy
1.1 per 1000 pregnancies 97% in fallopian tubes 2-3% interstitial (not extrauterine part of the tube) RF - IVF - Hx of pelvic infection - Adhesions from inflammation, infection or endometriosis - tubal surgery - IUD/IUD
84
Symptoms of ectopic pregnancy
``` Abdominal or pelvic pain Amenorrhoea or missed period Vaginal bleeding (with or without clots) ``` ``` Dizziness, fainting or syncope Breast tenderness Shoulder tip pain Urinary symptoms Passage of tissue Rectal pain or tenesmus Diarrhoea and vomiting ```
85
Signs of ectopic pregnancy
``` Pelvic or abdominal tenderness Adnexal tenderness Rebound tenderness Cervical tenderness Pallor Abdominal distension Enlarged uterus Tachycardia and/or hypotension Shock or collapse ```
86
Investigations of ectopic pregnancy
Pregnancy test in all women of child bearing age and lower abdominal pain - Transvaginal US most accurate - Need to identify: location of pregnancy, foetal pole, heartbeat - Serial hCG, 48 hours apart
87
Management of ectopic pregnancy
- Admit as emergency - Anti-D prophylaxis in all rhesus negative women - Conservative if hCG declining and patient clinically well MEDICAL - single dose methotrexate - First line if can return for follow up with no significant pain, unruptured, no intrauterine pregnancy on US and hCG <1500 - Contraception for 3-6 months due to methotrexate teratogenicitiy SURGICAL - If can't come for follow up OR - significant pain - adnexal mass >35mm - Foetal heartbeat visible - Serum hCG>5000 - Laparoscopic approach preferable - Salpingectomy - Complications: bleeding, infection, damage to surrounding organs
88
Describe BP in pregnancy
Falls slightly in 1st trimester due to decreased vascular resistance - Falls in 2nd to lowest point at 22-24 weeks - Increases in 3rd trimester to pre-pregnancy levels - Falls immediately after birth
89
Risks of hypertension in pregnancy
Abruptio placentae Cerebrovascular accident Disseminated Intravascular Coagulopathy Intrauterine growth restriction Prematurity Intrauterine death
90
Management of hypertension of pregnancy
Education on symptoms of pre-eclampsia - US at 34 weeks for foetal growth and amniotic fluid volume - High risk of pre-eclampsia then 75mg aspirin daily PRE-EXISTING - Review medication - Stop ACEi and ARBs - Keep BP <150/110 - Test for proteinuria regularly - US for foetal growth restriction, amniotic fluid volume MILD - 140/90 - Measure BP twice weekly and urine for protein at each visit MODERATE - 150-159/100-110 - Measure BP twice weekly - Start labetalol (alternatives: methyldopa, nifedipine) - Bloods SEVERE >160/110 - Admit, discharge when <150 - Measure BP at least 4 times per day
91
When should aspirin be given in pregnancy?
- Hypertension or pre-eclampsia in past pregnancy - CKD - Autoimmune disease - Diabetes mellitus - Chronic hypertension OR 2 of the following - first pregnancy - aged over 40 - previous pregnancy over 10 years ago - BMI > 35 - FHx of pre-eclampsia - multiple pregnancy
92
Definition of antepartum haemorrhage
Vaginal bleeding after week 24 of gestation and before 2nd stage of labour
93
Epidemiology and risk factors for antepartum haemorrhage
3-5% of pregnancies 20% of very preterm babies are associated with APH RFs depends on causes - Smoking - Cocaine use - Increasing maternal age - Increased parity - Pre-eclampsia - polyhydramnios
94
Aetiology of APH
No definitive cause found in 50% - Placenta praevia (insertion of placenta, partially or fully, in lower segment of the uterus) - Placental abruption (premature separation of normally placed placenta) - Local causes (vulval, cervical infection, trauma or tumours) - Domestic violence - Vasa praevia (bleeding from foetal vessels in foetal membranes, high risk of foetal haemorrhage) - Uterine rupture - Inherited bleeding problems
95
Presentation of APH
``` Bleeding With pain - abruption Without pain - praevia Uterine contractions Malpresentation or failure of head to engage Signs of foetal distress If severe - hypovolaemic shock ```
96
Investigations of APH
FBC Group and save Clotting studies ADMIT Urgent US for placenta praevia Foetal monitoring Rhesus negative women should have Kleihauer test - give anti-D after each bleed
97
Management of APH
Admit, even if only small amount of bleeding Estimate blood loss - Minor <50ml, Major 50-1000ml, massive>1000ml If foetal distress - urgent delivery regardless of gestation If severe bleeding - mother's life takes priority Give corticosteroids if gestation between 24 and 36 weeks
98
Definition of placenta praevia
Placenta inserted wholly or partially into the lower segment of the uterus MAJOR - placenta covers internal os of cervix MINOR - leading edge is in lower segment but not covering the os
99
Epidemiology and risk factors for placenta praevia
1/200 births 1/1000 are major Incidence is increasing RFs - Previous history of placenta praevia - Previous C-section - Increased maternal age - Increased parity - Smoking - Cocaine use during pregnancy - Previous spontaneous or induced abortion - Deficient endometrium due to past history of endometritis, manual removal of placenta, curettage - Assisted conception
100
Presentation of placenta praevia
Painless bleeding after 28th week - sudden, profuse, does not last long - 25% have spontaneous labour in the next few days - Can just have bleeding in labour or membrane rupture - High presenting part or abnormal lie - No foetal distress unless complications - Bleeding provoked by sexual intercourse
101
Diagnosis/ investigations of placenta praevia
Should have high index of suspicion in bleeding after 20 weeks. Diagnosis relies on US - Leading edge may be low on a 20 week scan - Apparent migration occurs during 2nd and 3rd trimester with development of lower uterine segment - Cannot exclude placental abruption (this is a clinical diagnosis) - TV US for all women whose placenta reaches or overlaps cervical os at anomaly scan - Minor - scan again at 36 weeks - major - scan again at 32 weeks Assists in planning and delivery
102
Management of placenta praevia
MINOR - may be able to deliver vaginally. Placental edge <2cm from the os = caesarean section If anterior, reaching os with history of C-section then treat as placenta accrete MAJOR - Deliver by C-section - No penetrative intercourse - Should admit to hospital from 34 weeks - Defer C-section to 38 weeks if possible
103
Placenta accrete and management
Morbidly adherent placenta - high risk if placenta praevia with history of C-section - Requires consultant obstetrician and anaesthetist - Blood products on site - MDT pre-op planning - Deliver baby without disturbing placenta - DO NOT PERFORM VAGINAL EXAM
104
Describe implantation bleeding
Light spotting or bleeding Occurs 10-14 days after conception NORMAL Occurs when fertilised egg attaches to lining of uterus
105
Describe normal placenta at term
Blue-red colour, discoid shape 450g in weight Maternal surface - divided into lobules or cotyledons with irregular grooves or clefts Foetal surface - smooth, shiny and translucent, choronic plane covered in amniotic membrane
106
Describe normal umbilical cord
50-60cm long Abundant Wharton's jelly, no true knots 2 umbilical arteries, 1 umbilical vein
107
Abnormalities of placental shape, size or surfaces
Circumvallate - foetal membranes double back on foetal side around edge of placenta, small central chorioic area inside a paler ring of membranes on foetal side Succenturiate lobe - accessory lobes, associated with retained placenta and increased infection Bipartate placenta - bilobed (uncommon) Placenta membranacea - failure of chorion to atrophy during development, placental cotyledons form envelope around greater part of uterine wall
108
Describe placenta accreta and levels
PLACENTA ACCRETA Placenta morbidly attached to uterine wall - chorionic villi penetrate the decidua basalis to attach to myometrium PLACENTA INCRETA villi penetrate deeply into myometrium PLACENTA PERCRETA villi breech myometrium into perioteum
109
Epidemiology of placenta accreta
1/2500 deliveries 40% deliver before 38 weeks C-section planned at 36-37 weeks RFs - Previous C-section - Placenta praevia - Increased age
110
Management of placenta accreta
Placenta is left in place with therapeutic uterine artery embolization, surgical internal iliac artery ligation or methotrexate therapy Elective hysterectomy later has less blood
111
Describe placental abruption
Premature separation of a normally placed placenta before delivery of the foetus with blood collecting between placenta and uterus - 30% of all APH - 6 per 1000 births Concealed (20%) - haemorrhage confined within uterine cavity, more severe as blood loss usually underestimated Revealed (80%) - blood drains through cervix
112
Risk factors for placental abruption
``` Previous abruption Pre-eclampsia Multiple pregnancy Threatened miscarriage Hypertension Multiparity Past C-section Smoking Non-vertex presentation Cocaine/amphetamines Thrombophilia Intrauterine infections Polyhydramnios Trauma - RTA, domestic violence, iatrogenic ```
113
Presentation of placental abruption
``` Vaginal bleeding Continuous abdominal pain Uterine contractions Shock Foetal distress ``` CLINICAL DIAGNOSIS - Tense, tender uterus with woody feel - Foetal hypoxia with HR abnormality on CTG - Low platelet count - Large level of compensation
114
Management of placental abruption
``` Mothers life takes priority ABCD Crossmatch 4 units Kleihauer test for anti-D Left lateral position ``` Delivery - If foetus alive, C-section or artificial rupture of amniotic membranes If foetus dead - vaginal delivery
115
Determining gestational age
Physical exam/US History - LMP Naegele's rule - EDD = -3months + 7 days from LMP Uterine size - 6-8weeks = small pear, 8-10 weeks = orange, 10-12weeks = grapefruit 16 weeks = midway pubic symphysis and umbilicus 20 weeks = umbilicus US - gestational sac diameter (until embryo visible) - Crown rump length - After 10 weeks - biparietal diameter and head circumference Foetal biometry - Biparietal diameter - Head circumference - Femur length - Abdominal circumference
116
Symptoms of pregnancy
``` Amenorrhoea Nausea and vomiting Breast enlargement and tenderness Increased urinary frequency Fatigue ``` ``` Uterine cramping Abdominal bloating Constipation heartburn SOB Mood changes Food cravings/aversions ```
117
Diagnosis of pregnancy
hCG - first secreted 6-8 days post ovulation - doubles every 30-50 hours during the first 30 days - slower rise in abnormal pregnancy - urine requires high levels to detect US - gestational sac at 4-5 weeks - yolk sac from 5 weeks to 10 weeks - foetal pole and cardiac activity 5-6 weeks
118
Reasons for pregnancy false positives
operator error (home kits) pregnancy loss soon after implantation interference from hCG from infertility treatment hCG from tumour Pituitary hCG secretion in perimenopausal women
119
Describe pre-eclampsia
Pregnancy induced hypertension in association with proteinuria +/- oedema Characterised by - Maternal hypertension - Proteinuria - Oedema - Foetal IUGR - premature birth Severe SBP > 160, diastolic >110 Foetus may have neurological damage post-hypoxia
120
Epidemiology and RF for pre-eclampsia
2nd leading cause of direct maternal death - 5 per 1000 - Death rate 0.4 per 100,000 - 20% stillbirths without congenital abnormality is caused by pre-eclampsia - 50% with severe will deliver by 36 weeks ``` RFs HIGH - past pre-eclampsia, eclampsia, hypertension in a previous pregnancy - pre-existing hypertension - Pre-existing CKD - Pre-existing diabetes - SLE or APLS ``` MODERATE - 10+ years since last pregnancy - first pregnancy - aged over 40 - BMI>35 - FHx of pre-eclampsia - multiple pregnancy
121
Pathophysiology of pre-eclampsia
Suboptimal uteroplacental perfusion associated with maternal inflammatory response and maternal vascular endothelial dysfunction Phase 1 - Abnormal placentation NORMAL - During 6-18 weeks placentation occurs - Alterations in spiral arteries occur to increase blood supply - Trophoblasts invade spiral arteries to 5x diameter - Coverts low flow, high pressure to low resistance, high flow PRE-ECLAMPSIA - inadequate trophoblast invasion, inadequate placental perfusion - Causes IUGR and pre-eclampsia Phase 2 - endothelial dysfunction - Platelet adhesion and thrombosis - Exaggerated maternal systemic inflammatory response - Decreased organ perfusion - HELLP
122
Presentation of pre-eclampsia
Systolic BP>140, diastolic >90 in 2nd half of pregnancy with >1+ of proteinuria - New hypertension - New proteinuria SEVERE - Severe frontal headache - Sudden swelling (oedema) - Liver tenderness - Visual disturbance - Epigastric pain - Vomiting - Low platelet count - Raised ALT and AST - Clonus - HELLP syndrome - Papilloedema - Foetal distress
123
Monitoring of pre-eclampsia
If patient has any risk factors - increasing frequency of BP and urine measurements Admit if they have: - BP>140/90, >1+ proteinuria - Systolic BP >160 - Diastolic >100 - Any symptoms or signs
124
Investigations of pre-eclampsia
- Urinanalysis - microscopy, culture - Frequent monitoring of FBC, LFTs, renal function, electrolytes & urate - Look for HELLP syndrome - Clotting if severe or thrombocytopaenia - 24 hour urine for protein and creatinine - Assessment of foetus - US and amniotic fluid
125
HELLP
Haemolysis Elevated Liver enzymes Low Platelets
126
Management of pre-eclampsia
Conservatively until at least 34 weeks where possible (no HELLP) Delivery of the placenta is the ONLY cure SEVERE - Antihypertensives (labetolol) if BP>160/110 Can also use nifedipine or hydralazine - Magnesium sulphate to prevent seizures - Fluid restruction - to minimise fluid overload which can result in pulmonary oedema - Delivery - If under 34 weeks, give corticosteroids - Method of delivery depends on presentation of foetus, foetal condition and chance of success - IM syntocinon to prevent haemorrhage - Prophylaxis against VTE
127
Management of eclampsia
``` Resuscitation Magnesium sulphate as anticonvulsant Intubation may be required if repeated seizures IV labetalol or hydralazine Continuous foetal monitoring Monitor fluid intake, and urine output Attempts to prolong pregnancy not of use ``` - it is unsafe to deliver a baby from an unstable mother - Control seizures, reduce HTN and correct hypoxia - c-section
128
Complications of pre-eclampsia
``` Haemolysis HELLP AKI DIC Adult respiratory distress syndrome Cerebrovascular haemorrhage ```
129
Prevention of pre-eclampsia
75mg aspirin from 12 weeks if high risk
130
Maternal issues associated with substance misuse in pregnancy
``` Low nutrition Risk of anaemia Oral hygiene issues Infection from needles Increased risk of mental health problems Increased obstetric complications Increased premature delivery ```
131
Foetal issues associated with substance misuse in pregnancy
``` IUGR Pre-term delivery Increase perinatal mortality Increased miscarriage Increased placental abruption ```
132
Management of opioid addiction in pregnancy
Maintenance with methadone to stop/minimise illicit use Detox in first trimester has high miscarriage risk Can detox in 2nd or 3rd trimester, small frequent reductions Withdrawal will increase foetal distress and still birth
133
Management of a cocaine use in pregnancy
STOP - no safe prescribed alternative
134
Risks of cocaine in pregnancy
Increased miscarriage, still birth PROM Placental abruption Preterm labour For baby - stroke - poor growth - deformed limbs - feedbing problems - brain damage - SIDS NO BREAST FEEDING
135
Risks of opiates in pregnancy
Increased pre term delivery Still born IUGR Increased neonatal death Neonatal withdrawal syndrome - high pitch cry, poor feeding, tremors, irritability, D&V, sweating, seizures ``` Heroin = NO BREAST FEEDING Opiates = OK to breastfeed ```
136
Induction of labour
60-80% success rate Starting labour by uterine stimulation. Approximately 20% of births. Offer to women in healthy pregnancy over 41 weeks to decrease risk of still birth Offer to diabetic women before term Offer if PROM after 37 weeks - Membrane sweep - Prostaglandin gel or pessary (PV) - Oxytocin +/- artificial rupture of membranes Monitor with CTG for myometrial over-reaction
137
Contraindications for induction of labour
``` Severe placenta praevia Transverse foetal lie Severe cephalopelvic disproportion Cervix <4 on Bishop's score Active primary genital herpes infection High and floating foetal head (risk of prolapsed cord) ```
138
Complications of induction of labour
Uterine Hyperstimulation - foetal distress, hypoxic damage Uterine rupture Intrauterine infection with prolonged membrane rupture Prolapsed cord if presenting part not engaged Amniotic fluid embolization Atonic PPH
139
Prevention for instrumental delivery
Presence of supporting person with the woman at all times Mother labouring in upright or left lateral position Avoidance of epidurals
140
What is Bishop's system?
Score for ripeness of cervix | >8 = successful delivery
141
Classification of forceps deliveries
OUTLET - foetal scalp visible, labia separated Foetal skull has reached pelvic floor Rotation required > 45 degrees LOW - leading point (not caput) is at +2, rotation required MIDCAVITY - head 1/5 palpable per abdomen, leading point >2+ but not above ischial spines HIGH = not recommeded
142
Indications for instrumental delivery
Presumed or diagnosed foetal compromise Protect head during breech delivery ``` MATERNAL Avoid Valsalva manourvre Hypertensive crisis CV disease Myasthenia gravis Spinal cord injury ``` Inadequate progress - Active stage > 2 hours in nulliparous, >1 hour in multiparous - Maternal fatigue
143
Contraindications for instrumental delivery
Predisposition to fractures in foetus Bleeding tendency or active bleeding in foetus Face presentation Vacuum extractor should not be used under 34 weeks
144
Requirements for an instrumental delivery
``` Fully dilated cervix Occipital-anterior position Ruptured membranes Cephalic presentation Engaged presenting part Pain relief adequate Sphincter (bladder) empty ``` Mediolateral episiotomy before instrumental delivery to reduce tears If unsuccessful with 3 pulls - c-section
145
Indications for episiotomy
``` Rigid perineum preventing delivery Large tear imminent Instrumetnal delivery Shoulder dystocia Vaginal breech delivery ```
146
What is an episiotomy
Right mediolateral incision with local anaesthetic
147
Degrees of tears
1st - injury to vaginal epithelium and vulval skin only 2nd - injury to perineal muscles but not anal sphincter 3rd - injury to perineum, involving anal sphincter 4th - injury to perineum, anal sphincter complex and anal or rectal mucosa
148
Indications for induction of labour
``` uteroplacental insufficiency prolonged pregnancy > 41 weeks IUGR Oligo or anhydramnios Abnormal uterine or umbilical artery Doppler Non-reassuring CTG PROM Severe pre-eclampsia, eclampsia Intrauterine death of foetus APH Chorioamnitis ``` Severe hypertension Uncontrolled diabetes Deteriorating renal function Malignancy
149
Methods for induction of labour
Cervical ripening - Separation of membranes from the cervix - stretch and sweep Amniotomy - Artificial rupture of membranes Prostaglandins - DINOPROSTONE - Intravaginally as tablets or gel - VE after 6 hours - CTG before and after - Only 2 doses as risk of Hyperstimulation Oxytocin infusion - best after rupture of membranes - wait 6 hours after prostaglandins - continuous CTG and want 3-4 contractions in 10 minutes
150
First stage of labour
Begins with regular contractions when the foetal presenting part has reached true pelvis End when the cervix is fully dilated (10 cm) Latent phase - 2-24 hours - Cotnractions not painful, 5-10 minute intervals - Cervix dilating slowily ACTIVE PHASE - Primi - 12-14 hours, multi 6-10 hours - Start when cervix 3-4 cm dilated - Rapid dilation 0.5-1cm per hour - Foetal head descends into maternal pelvis and foetal neck flexes
151
Management of first stage of labour
Hourly temp and HR 4 hourly BP 30 minute monitoring frequency of contractions Foetal HR auscultated for 1 minute immediately after a contraction every 15 minutes Should be 100-160 VE every 4 hours Discuss need for pain relief
152
Second stage of labour
Starts when cervix is fully dilated Ends with birth of baby Contractions are stronger, 2-5 minute intervals lasting 60-90 seconds Primigravida 60 minutes, multi 30 minutes Feotal head descends and rotates anteriorly Wants to push After head through, shoulders rotate to allow shoulders through Midwife/doctor present throughout Monitor contractions, and foetal HR ever 5 minutes Push during contractions, relax between If >2 hours nulliparous or > 1 hour multiparous then consider instrumental delivery or c-section
153
Third stage of labour
Starts with birth of baby Ends with delivery of placenta and membranes Separation of placenta occurs immediately after birth 20-30 minutes or 5-15 with active management Haemorrhaging prevented by contraction of uterine muscle fibres Separation noted by gush of blood, prominence of fundus in abdomen and lengthening of umbilical cord
154
Management of 3rd stage of labour
Expectant - uterus rubbed up to produce contraction, uterus pushed to vagina to aid expulsion Active - IM oxytocin after birth Controlled traction of umbilical cord to aid expulsion Examine placenta and membranes for completeness
155
Braxton Hicks contraction
Mild Irregular Non-progressive can occur from 30 weeks, more common after 36 weeks
156
Poor progress in 1st stage of labour - Criteria - Causes
Criteria <2cm progression in 4 hours - Slowing in progress in parous woman ``` Insufficient uterine activity (power) Malpositions, malpresentation, large baby (passenger) Inadequate pelvis (passage) ```
157
Management of poor progress in 1st stage of labour
Amniotomy and reassess in 2 hours Amniotomy + oxytocin infusion C-section if foetal distress
158
Benefits of active management of 3rd stage of labour
``` Decreased PPH Decreased length of time in 3rd stage Decrease blood loss Decreased post-natal anaemia Decreased transfusions ```
159
Definition of premature labour
Contractions of sufficient strength and frequency to effect progressive effacement and dilation of cervix before 37 weeks Very premature is before 32 weeks
160
Risk factors for premature labour
``` Multiple pregnancy Genital tract infection P-PROM Antepartum haemorrhage Cervical incompetence Congenital uterine abnormality APLS Diabetes Past pre-term delivery ``` 30% are unexplained and spontaneous
161
Investigations for pre-term labour
If under 30 weeks with in tact membranes, no investigations If over 30 weeks - TV US to estimate cervical length - Foetal fibronectin: if less than 50 then unlikely to be pre-term labour No VE if ruptured membranes unless confirmed labour Vaginal swabs
162
Management of pre-term labour
Tocolytic drugs - not if P-PROM - Nifedipine - Can delay delivery for up to 7 days Corticosteroids if between 24 and 36 weeks Magnesium sulphate to reduce risk of CP Emergency cervical cerclage if between 16 and 34 weeks with dilated cervix and exposed unruptured membranes Delivery vaginally if cephalic Breech under 32 weeks = C-section Most over 30 weeks survive without lasting abnormality
163
Non-pharmacological methods of pain relief in labour
Maternal support Environment - light diet, keep mobile, soothing music, comfortable position Birthing pool - not within 2 hours of opioids due to drowsiness
164
Drugs used as analgesia in labour
Entonox - Inhaled - Patient controlled, works in seconds, wears off quickly, minimal side effects IM opiate - SE nausea, vomiting, drowsiness - Pethidine - Short term respiratory depression and drowsiness - Drowsy neonate Epidural - Central nerve block with local anaesthetic - Most effective, avoids further analgesia for instrumental delivery. - Increases length of 2nd stage, rate of operative delivery - Can cause transient hypotension, dizziness - Severe headache if dural tap - need CTG Local anaesthesia - if tear, episiotomy or instrumental delivery
165
Differences between epidural and spinal
Epidural - extradural catheter placement - cannula allows top up - patchy analgesia Spinal - subarachnoid injection - 1 off injection, can last 2-4 hours - dense, reliable block
166
Causes of cerebral palsy
``` Unknown Complication of prematurity Peripartum asphyxia Postnatal (encephalitis, accidents) Perinatal infection (CMV, rubella) Multiple pregnancy Chromosomal abnormality ```
167
Types of multiple pregnancy
Dizygotic - non identical twins - Foetus has it's own placenta, own amnion and chorion Monozygotic Depends on when the embryo splits - 3 days: 2 chorion, 2 amnion - 4-7 days, 1 placenta, 1 chorion, 2 amnion - 8-12 days: 1 placenta, 1 chorion, 1 amnion - 13 days - conjoined twins
168
Risk factors for multiple pregnancy
RFs at only for dizygotic twins - monozygotic has no RFs ``` - Past multiple pregnancy FHx on maternal side Increased maternal age West African Assisted conception ```
169
Antenatal care in multiple pregnancy
Refer to obstetrics US as normal at 11-13 wees and 18-20 for abnormality Monitor carefully for IUGR and feto-feto transfusion syndrome Scan Dichorionic - 20, 24, 28, 32 and 26 weeks Monochorionic - 18, 20, 22, 24, 26, 28, 30, 32 and 34 weeks Inform - increased risk of Down's and increased risk of false positive on screening - Twins use combined test - Triplets use nuchal translucency Take 75mg aspirin OD from 12 weeks if 1st pregnancy, over 40, pregnancy interval over 10 years, BMI > 35or FHx of pre-eclapmsia
170
Delivery of multiple pregnancy
Offer elective birth at 36 weeks (mono-chorionic) after course of steroids Dichorionic - 37 weeks Triplets - 35 weeks If 1st twin is cephalic presentation then trial vaginal delivery, if breech or transverse then C-section - May need IV oxytocin after first child as contractions can decrease - 2nd should be born within 45 minutes
171
Maternal complications of multiple prengnacy
``` Increased miscarriage anaemia pre-eclampsia APH PPH C-section symptoms of pregnancy Polyhydramnios Hyperemesis gravidarum Post natal illness death ```
172
Foetal complications of multiple prengancy
``` Increased Still birth pre-term birth neonatal mortality morbidity FFTS Umbilical entanglement IUGR congenital abnormality ```
173
Physiological changes in prengnacy
``` Increased blood volume Decreased Hct (due to dilution) - anaemia of pregnancy is physiological Increased RBC Increased stroke volume, cardiac output Decreased peripheral vascular resistance BP stable or decreased ``` Increased tidal volume Decreased functional residual capacity from gravid uterus Decreased total lung capacity Increased clotting Increased renal function increased uterine blood flow Increased uterine weight No autoregularion of uterine blood flow - hypotension can cause foetal distress
174
Why is left lateral an important position in pregnancy
Otherwise can have overt caval compression- IVC compression - Hypotension - Sweating - Bradycardia - Pallor - Nausea and vomiting
175
Spinal anaesthesia
L3/L4 Pierce the ligamentum flavum before dura Use heavy LA to prevent upwards movement Uterus supply at T10 - block up to nipple line (T4) Phenyepherine - alpha blocker to counteract hypotension Inject bupropripcaine - 20x safer than GA
176
GA in prengancy
``` Avoid at all costs Need to neutralise stomach acid with ranitidine and metoclopramide No strong opioids prior to delivery Difficult airway Give +++ oxygen before anaesthesia ``` Only if spinal or epidural contraindicated e.g. raised ICP, coagulopathy, patient refusal or infection
177
Reasons for CTG
``` MATERNAL Past C-section cardiac problems pre-eclampsia prolonged pregnancy >42 weeks PROM induction of labour Diabetes APH ``` ``` FOETAL IUGR prematurity oligohydramnios abnormal Doppler multiple pregnancy meconium stained liquor breech position ``` ``` INTRAPARTUM oxytocin augmentation epidural anaesthesia intrapartum PV bleed pyrexia > 37.5 fresh meconium bleeding abnormal foetal HR prolonged labour ```
178
Normal baseline foetal HR
110-160 Bradycardia <110 Tachycardia > 160
179
Normal baseline variability on CTG
Normal 5-25bpm Reduced 0-5 Saltatory >25
180
Define acceleration and deceleration on CTG
Transient rise in FHR > 15 bpm for >15 seconds Transient decrease as above Early decelerations - peaks co-incides with contraction and is due to head compression - 2nd stage of labour Late decelerations - acidosis, if shallow with decrease baseline variability very concerning
181
Maternal factors that can cause abnormal CTG
``` Position - not left lateral Hypotension VE Emptying bladder or bowels Vomiting Vasovagal episodes Topping up anaesthesia ```
182
Foetal blood sampling
Taken from scalp via needle and speculum Obtain if pathological CTG Woman in L lateral Normal ph>7.25 then repeat in 1 hour if CTG still abnormal Borderline 7.21-7.24, repeat in 30 mins Abnormal <7.20 IMMEDIATE DELIVERY
183
RF for pre term premature rupture of membranes P-PROM
Smoking Previous pre-term delivery Vaginal bleeding Lower genital tract infection
184
Investigations for PROM
``` No VE Visualise amniotic fluid draining through cervix Sterile speculum exam US to determine liquor volume 12 hourly temperatures Foetal monitoring ```
185
Management of PROM
Refer to hospital, admit for first 48 hours Prophylactic antibiotics Antenatal steroids if between 24 and 35 weeks Consider delivery post-34 weeks
186
Complications of PROM
``` prematurity Sepsis Pulmonary hypoplasia Umbilical cord prolapse Placental abruption Oligohydramnios Increased retained placenta and PPH ```
187
Epidemiology and RF for post-natal depression
As common as depression Most common in first few weeks post-natally 10-15% ``` MAJOR RF Previous history of MH problems Psychological disturbance in pregnancy Poor social support Poor relationship with partner Baby blues Recent major life events ``` ``` Other RF Unplanned pregnancy Not breast feeding Unemployment Antenatal parental stress Depression in father 2+ children Neonatal illness/death/SIDS Substance misuse Low family outcome History of abuse ```
188
Presentation of post-natal depression
``` Low mood Anhedonia Anxiety Disturbed sleep Decreased appetite Poor concentration Decreased self-esteem Decreased energy Decreased libido Suicidal thoughts ```
189
Assessment of post-natal depression | Questions to be asked in history
``` Hx or FHx or MH problem Physical wellbeing Alcohol and drug misuse Mother-baby relationship Relationships, social networks, isolation Domestic violence, abuse, sexual abuse, trauma Housing Employment Economic and migration status ```
190
Management of post-natal depression
Mild-moderate = consider self-help strategies Mild + history of severe depression = consider antidepressant Moderate-severe = CBT, antidepressants or combination Psychological therapies are first line Women can breastfeed unless taking = lithium, sodium valproate, carbamazepine, clozapine Higher threshold for pharmacological therapy due to risk
191
Complications in post natal depression
Adverse effects in the children Poorer cognitive, emotional, social and behavioural development Post-partum psychosis 1/1000 - first few weeks - psychiatric emergency - paranoia, delusions, hallucinations, loss of inhibition Most resolves in 3-6 months Course of illness widely variable
192
Incidence and factors that increase breast feeding
81% of mothers, increasing 1/3 are still breast feeding at 6 months Only 1% are exclusive breast feeding at 6 months More likely to breast feed if... - From ethnic minority group (Chinese, black) - managerial and professional occupation - aged over 30 - Live in England (vs. rest of GB) - First time mother - Left full time education over 18
193
Advantages of breast feeding
``` Free No preparation Immunity Infection protection (decreased LRTI, otitis media, gastroenteritis) May protect against asthma and eczema Decrease SIDS Protection from future Type 2 diabetes (in mother and child) Decrease breast and ovarian cancer Contraception - lactational amenorrhoea ```
194
Disadvantages of breast feeding
issues with feeding in public low in vitamin D (may need supplements) transmission of HIV and hep C Can transmit maternal infection - N. gonorrhoea, H. influenza, group B strep, staph cracked/sore nipples blocked ducts and breast engorgement mastitis thrush
195
Causes of cracked and sore nipples (breast feeding)
Nipple soreness is very common in the first few weeks Caused by - improper positioning of baby - alter - improper feeding technique - incomplete suction release - improper nipple care - excessively dry or moist
196
Blocked ducts and breast engorgement (breast feeding)
caused by poor drainage of the breast swollen, hard, painful, redness nipples can protrude to allow baby to latch causes by pressure on breast and prolonged gaps between feeds nurse 8+ times in 24 hours for 15+ minutes can develop in mastitis if persists
197
Mastitis (breast feeding)
occurs in 20% Increased if: nipple damage, over supply of milk, S.aureus Engorgement can lead to mastitis which can lead to abscess Treat with flucloxacillin
198
Advice for breast feeding mothers
Should begin within an hour of birth It should be on demand - when baby wants it Avoid pacifiers or bottles Baby head and body in line Hold baby close Place baby nipple to nose - baby will tip head back Milk released by oxytocin
199
Define neonatal abstinence syndrome
Infant born to mother addicted to opioids at the risk of withdrawal. - Heroin - Methadone
200
Presentation of neonatal abstinence syndrome
CNS - tremors - irritability - increased wakefulness - high pitched cry - hypertonicity - hyperactive reflexes - seziurs - yawning, sneezing GI TRACT - poor feeding - uncoordinated, constant sucking - vomiting - regurgitation - loose, watery stools - dehydration AUTONOMIC - increased sweating - nasal stuffiness - fever - temperature instability - tachypnoea - mottling of skin Starts within 24 hours if heroin or 24-72 days if methadone
201
Management of neonatal abstinence syndrome
Decrease sensory stimulation Small frequent feeding Increased calorie dense formula MONITOR Pharmacology if seizures, poor feeding, fever, significant D&V Opioid therapy - morphine/methadone/buprenorphine Adjunct therapy if multiple drug exposure = phenobarbital
202
Information required for post-partum contraception advice
Normally discussed at 6 week GP check ``` Contraceptive needs Future child plans Any periods Breastfeeding Any medical conditions ```
203
Contraception for non-breast feeding mother under 21 days post partum
Barrier methods POP Progesterone only injectable and implants
204
Contraception for non-breast feeding mother over 21 days post partum
COCP Barrier methods POP Progesterone only injectable and implant IUS over 6 weeks
205
Contraception for breast feeding mother under 6 weeks post partum
Lactational amenorrhoea methods POP Progesterone only implants Barrier methods
206
Contraception for breast feeding mother over 6 weeks post partum
``` LAM POP Progesterone injectable and implant IUS - from 6 weeks IUD Barrier methods Sterilisation ``` No COCP until after 6 months
207
Criteria for lactational amenorrhoea methods
Under 6 months post partum Amennorhoeic Full daily breast feeding
208
Define 3rd stage of labour
From the time of birth to expulsion of placenta
209
Define prolonged 3rd stage of labour
Prolonged if not completed in: 30 minutes - active 60 minutes - physiological
210
Describe management of 3rd stage of labour
Active management - routine use of uterogenic drugs - oxytocin IM with birth of anterior shoulder - deferred clamping and cutting of cord (between 1 minutes to 5 minutes) - controlled cord traction Physiological - delivery of placenta by maternal effort
211
Care of newborn immediately post-partum
Apgar score at 1 minute and 5 minutes Record time from birth to regular respirations Skin to skin contact Avoid separation of mother and baby for 1 hours Encourage breast feeding within 1st hour Record head circumference, body temp and weight
212
Care of mother immediately post-partum
``` Assess uterine contraction and lochia Examine placenta and membranes Assess emotional and physical condition Successful voiding of bladder Assess for genital trauma If genital trauma then rectal exam If required perineal repair ```
213
Define post-partum haemorrhage
Excessive bleeding post-delivery Primary - loss of blood >500ml within 24 hours of delivery MINOR - 500-1000ml MAJOR - over 1000ml Secondary - abnormal bleeding between 24 hours and 6 weeks
214
Aetiology of PPH
Tone - uterine atony (most common), distended bladder Trauma - lacerations of uterus, cervix or vagina Tissue - retained placenta, clots Thrombin - pre-existing or acquired coagulopathy
215
Epidemiology and RF for PPH
5-10% Severe less than 1% Increased in Asians Increased in over 40s Antenatal RF - APH - Placenta praevia (x12) - Placental abruption - Multiple pregnancy (x5) - Uterine over-distension (polyhydramnios, macrosomia) - pre-eclampsia - multi parity > 4 - previous PPH or retained placenta - increased if BMI > 35 Delivery RFs - emergency section (x4) - elective seciont (x2) - Retained placenta (x5) - episiotomy (x5) - induction of labour - instrumented delivery - labour > 12 hours - Baby > 4kg - Maternal pyrexia in labour Clotting disorders
216
Management of PPH
Resusciattion - Minor = 14G cannula and crystalloid infusion - Major = ABCs, high flow O2, 2x14G cannula, transfuse bloods ASAP and Hartmanns until blood available Monitor and investigate - Minor = blood group, coag screen - Major = FBC, coag, U&E, LFTs, crossmatch 4 units. Consider arterial line and ITU transfer, MEOWS charts Stop bleeding - If uterine atony: - bimanual uterine compression - empty bladder - oxytocin infusion - ergometrine - carboprost or misoprostol - balloon tamponade - haemostatic brace suturing - bilateral ligation of uterine or internal iliac arteries - selective arterial embolization Hysterectomy - should be a 2 consultant decision
217
Complications from primary PPH
``` Hypovolaemic shock DIC AKI Liver failure Acute respiratory distress syndrome Death in 1 in 100,000 deliveries ```
218
Aetiology of secondary PPH
Infection - endometritis | Retained products of conception
219
RF for secondary PPH
1-3% of vaginal deliveries ``` C-section prolonged rupture of membranes severe meconium staining in liquor long labour with multiple examinations manual removal of placenta extremes of maternal age decreased socio economic status maternal anaemia prolonged surgery ```
220
symptoms of secondary PPH
``` fever abdominal pain offensive smelling lochia abnormal vaginal bleeding abnormal vaginal discharge dyspareunia dysuria malaise ```
221
signs of secondary PPH
``` fever rigors tachycardia tenderness of suprapubic area and adnexa elevated boggy uterus if retained products of conception ```
222
Investigations for secondary PPH
``` FBC Blood cultures MSU High vaginal swab - gonorrhoea, chlamydia US if ?RPOC ```
223
Management of secondary PPH
Urgent referral if any red flags (sepsis) - pyrexia >38 - sustained tachycardia >>90 - RR >20 - abdominal and chest pain - D+V - uterine or renal angle pain - IV antibiotics (for endometriits) - piperacilin/taxobactam (tazocin)
224
Epidemiology of cervical cancer
``` Increased in developing countries 30% detected through screening 13th most common cancer in females 1 per 10,000 Peak age 25-29 ``` RF - HPV 16 and 18 - Heterosexual - multiple sexual partner - Smoking - Lower social class - Immunosuppression - COCP
225
Pathogenesis of cervical cancer
70% squamous carcinoma 15% adenocarcinoma 15% mixed CIN - CIN1 - disease confined to lower 1/3 epithelium - CIN2 - confined to lower and middle 1/3 of epithelium - CIN3 - full thickness of epithelium
226
Symptoms of cervical cancer
``` Abnormal vaginal bleeding vaginal discharge bleeding - post coital, on micturition or defaecation Vaginal discomfort Urinary symptoms ``` Late symptoms - painless haematuria - chronic urinary frequency - painless fresh rectal bleeding - altered bowel habit - leg oedema, pain, hydronephrosis If any suspicion refer on 2 week wait, do not do a smear
227
Signs of cervical cancer
``` White patches on cervix Abnormal cervical appearance - erosion, ulcer, tumour Mass on rectal exam Pelvic bulkiness or mass peripheral oedema Hepatic/pulmonary mets ```
228
Investigations for cervical cancer
Pre-menopausal - STI screen Post-menopausal - urgent gynae referral ``` Colposcopy - cleaned with acetic acid - Insepction +/- biopsy +/- treatment Cone biopsy FBC, U&Es, LFTs ```
229
Staging of cervical cancer
``` FIGO staging Based on tumour size Vaginal or parametrial involvement Bladder or rectum involvement Mets ``` Most are diagnosed in early stages
230
Management of cervical cancer
Surgery, radiotherapy, chemotherapy or combination Fertility sparing treatment may be important If pregnant may delay for a few weeks or abort Surgery - If fertility sparing, removal with margins - Or hysterectomy - Radical: Wertheim's hysterectomy: tumour + main lymph nodes + upper 1/3 vagina Radiotherapy - external beam or internal brachytherapy Chemo - cisplatin
231
Prognosis of cervical cancer
``` 1 = 90% survival at 5 years 2 = 60-90% 3 = 30-50% 4 = <20% ```
232
Prevention of cervical cancer
HPV vaccine 16 and 18 or 16, 8, 6 and 11 (includes for warts) - Given in females aged 11 to 13 2 doses
233
Screening for cervical cancer
From 25 Every 3 years until 50 After 50 every 5 years until 65
234
Pathophysiology of endometrial cancer
Mainly adenocarcinoma from lining of uterus | OESTROGEN DEPENDENT
235
Epidemiology of endometrial cancer
90% are over 50 Increased with age Most common in Western societies 3% of total cancer cases RF - prolonged periods of unopposed oestrogen - Nulliparous - Post menopausal - Obesity - Endometrial hyperplasia - PCOS - HNPCC - Diabetes - Tamoxifen
236
Presentation of endometrial cancer
POST MENOPAUSAL BLEEDING IS endometrial cancer unless proven otherwise
237
Investigations for endometrial cancer
TV US - 3mm cut off for endometrial cancer Endometrial biopsy - pipelle - done as outpatient and offers definitive diagnosis - hysteroscopy and biopsy
238
Management of endometrial cancer
TAH and BSO for all If stage 2 - TAHBSO and systematic pelvic node clearance If stage 3/4 - debulking surgery - surgery/radio/chemotherapy
239
Types of ovarian cancer
Epithelial (85-90%) - In over 50s - Serous is most common subtype (40-60 years) - Endometroid - Clear cell tumour - Mucinous tumour Germ cell (2-10%) - derived from germ cells of embryonic gonad - <35 - Curable - Rapid enlarging, bloating, pain, rupture, torsion - Dysgerminoma, endodermal sinus tumours, teratoma, embryonal carcinoma, choriocarcinoma Sex cord stromal tumour (<5%) - derived from connective tissue cells Borderline (10-15%) - Not benign or malignant - Do not respond well to chemotherapy
240
Epidemiology of ovarian cancer
2% lifetime risk 17 per 100,000 Peaks in 70-80s RF - Increasing age - Smoking - Obesity - Decreased exercise - Talcum powder use pre 1975 (asbestos) - Hx of infertility or treatment - Nulliparous - FHx - BRCA1 or 2 - Endometriosis - HRT Protective factors - COCP, child bearing, breastfeeding, early menopause
241
Presentation of ovarian cancer
``` 58% present with stage 3 or 4 Insidious onset - Abdominal discomfort Distension Bloating Urinary frequency Dyspepsia Pelvic or abdominal mass associated with pain Abnormal uterine bleeding Ascites Pleural effusion ```
242
Investigations for ovarian cancer
Refer with any mass or ascites Test over 50s if symptomatic with multiple attendances Test over 50s with new IBS CA125 If raised then US and refer CT pelvis and abdo for staging If aged under 40, alpha fetoprotein (endodermal sinus tumours) - beta hCG for dysgerminomas, embryonal carcinoma, choriocarcinoma Biopsy prior to chemotherapy
243
Staging of ovarian cancer
1 limited to ovaries 2 one or both ovaries with pelvic extension 3 microscopically confirmed peritoneal deposits outside pelvic 4 distant mets
244
Management of ovarian cancer
Explorative laparotomy for staging and tumour debulking TAH and BSO Conservative if fertility sparing Chemo post surgery - Paclitaxel and carboplatin Relapses are treated with chemotherapy CA125 useful for monitoring
245
Complications of ovarian cancer
``` Torsion Rupture Infection Malnutrition Electrolyte imbalance Bowel obstruction Ascites Pleural effusion ``` 10 year survival 35% Better outcome if under 40
246
Define metorrhagia
Irregular and frequent periods
247
Aetiology of post-coital bleeding
``` Infection Cervical ectropion Cervical or endometrial polyps Vaginal cancer Cervical cancer Trauma ``` No specific cause is found in 50%
248
Aetiology of intermenstrual bleeding
``` Pregnancy related - ectopic, GTD Physiological - 1-2% spot around ovulation Vaginal - adenosis, vaginitis, tumour STI Cervical cancer Cervical/endometrial polyps Ectropion Fibroids Endometrial cancer Adenomyosis Enodmetritis Oestrogen secreting ovarian cancers ``` Tamoxifen Missed oral contraceptive Drugs altering clotting - anticoagulants, SSRIs, steroids Dysfunctional uterine bleeding
249
History features for vaginal bleeding
``` LMP Usual cycle length and regularity Duration of abnormal bleeding Menorrhagia? Associated symptoms - abdo pain, fever, vaginal discharge, dyspareunia, aggravating factors ``` Previous pregnancies and deliveries Risk of current pregnancy RF for ectopic - PID, IVF, IUCD, POCP Current contraception Smear history Past gynae investigations or surgery Sexual history - STIs Medical history - diabetes, bleeding disorders Current medications
250
Cervical ectropion
red ring around external os due to extension of endocervical columnar epithelium over ectocervix More common in young people on COCP
251
Cervicitis
red, congested oedematous cervix May have purulent discharge with tender cervix on palpation Chlamydia or gonorrhoea
252
Strawberry cervix
Trichomonas vaginalis infection Cervix is friable Prominent papillae Punctate haemorrhages
253
When to refer a woman with PV bleeding
Women with abnormal looking cervix Suspicious looking cervical polyp Pelvic mass High risk of endometrial cancer (Fhx, prolonged or irregular cycles, on tamoxifen Over 45 + IMB Under 45 with persistent symptoms or RFs for endometrial cancer
254
Investigations for PV bleeding
``` Always exclude pregnancy Exclude STI Smears only if due FBC, clotting, TFT, FSH/LH TV US is investigation of choice (best to do immediately post-menstrually as thinnest and cysts and polyps most obvious) Endometrial biopsy using Pipelle Colposcopy ```
255
Define polymenorrhoea
Bleeding at intervals <21 days
256
Dysfunctional uterine bleeding
Abnormal uterine bleeding without any structural or systemic pathology Usually menorrhagia Diagnosis of exclusion
257
Aetiology of menorrhagia
``` 40-60% have no pathology 20% anovulatory cycles Fibroids Endometrial polyps Endometriosis Adenomyosis PID Endometritis Endometrial hyperplasia/carcinoma Systemic disease - hypothyroid, liver or kidney disease, obesity, bleeding disorder IUCD Anticoagulants ```
258
Investigations for menorrhagia
``` FBC Haemotinics (iron deficiency) TFTs Assessment of bleeding disorders US to assess underlying pathology ```
259
Management of menorrhagia
Pharmacological 1. Mirena IUS 2. Tranexamic acid, NSAIDs (mefamic acid), COCP 3. Progestogens - POP or depot 4. 3-4 months of gonadotrophin releasing hormone (GnRH) 5. Hysterectomy/myomectomy Surgical - Endometrial ablation if not enlarged utuerus (not if large fibroids) - Radiofrequency/microwave etc. - Uterine artery embolization (if wish to keep uterus) - Hysteroscopic myomectomy - Hysterectomy
260
Complications of endometrial ablation
``` Vaginal discharge Increased period pain Need for additional surgery Infection Perforation ```
261
Fibroid
Bengin monoclonal tumours of smooth muscle cells of uterine myometrium with disordered collagen Growth is stimulated by oestrogens and progesterone
262
Classification of fibroids
Intramural (most ) Submucosal (growing into uterine cavity) Subserosal - growing outwards from uterus
263
Epidemiology of fibroids
77% of women Increased in Africans 30-40 years old FHx (x2.5 if first degree relative) RF - Obesity - Early menarche Protective factors: increased parity, smoking and exercise
264
Presentation of fibroids
50% are asymptomatic 30-50 years old Excessive or prolonged heavy periods IMB Pelvic pain (especially in pregnancy due to pressure and resultant fibroid degeneration) Constipation/ urinary symptoms from pressure Recurrent miscarriage or infertility (only if submucosal) Palpable mass Enlarged irregular firm non-tender uterus Iron deficiency anaemia
265
Investigations for fibroids
``` Pregnancy test FBC and haematinics TV US MRI if US not definitive Endometrial sampling with pipelle for other causes Hysteroscopy and biopsy ```
266
Management of fibroids
- NSAIDs to reduce blood loss - Transexamic acid - COCP - Mirena coil - GnRH agonists decrease size but will regrow when stopped - Surgery: if pressure symptoms, increased uterine size, medical treatment insufficient or fertility affected - Myomectomy (recurrence rate 3%) - Hysteroscopic endometrial ablation - Laparoscopic hysterectomy
267
Complications of fibroids
``` Iron deficiency anaemia Bladder frequency Constipation Infertility Problems in pregnancy - miscarriage, premature labour and PPH, IUGR. ```
268
Define endometriosis
Chronic oestrogen dependent condition characterised by growth of endometrial tissues in sites other than the uterine cavity
269
Most common sites for endometriosis
``` Pelvic cavity including ovaries Uterosacral ligaments Pouch of Douglas Rectosigmoid colon Bladder and distal ureter Rare sites - umbilicus, scar sites, pleura, pericardium, CNS ```
270
Define adenomyosis
Invasion of myometrium by endometrial tissue
271
Epidemiology of endometriosis
10-15% of women of reproductive age Exclusive to reproductive age Diagnosed in 30s ``` RFs - Infertile - Early menarche - Delayed child bearing - Long duration of menstrual flow - Obstruction to vaginal flow (hydrocolpos) - FHx (6x with first degree relative) Chromosomes 7 and 10 ``` Protective; multiparity and use of oral contraceptives
272
Symptoms of endometriosis
``` Dysmenorrhoea (painful periods) Dyspareunia Cyclical or chronic pelvic pain Subfertility Bloating Lethargy Constipation Lower back pain ``` ``` Less common: cyclical rectal bleeding menorrhagia diarrhoea haematuria ``` Severity of symptoms increase with age Worsening of symptoms at the time of menstruation or just prior to it
273
Signs of endometriosis
``` Examination often normal Posterior fornix or adenexal tenderness Palpable nodules Bluish haemorrhagic nodules in posterior fornix Chocolate cysts on ovaries ```
274
Investigations for endometriosis
Lapararoscopy is gold standard Symptoms and laparoscopic findings do not always correlate TV US to exclude ovarian pathology ``` FBC, Urinalysis Cervical swabs beta hCG MRI may be useful ```
275
Management of endometriosis
Medical treatment may decrease symptoms in 80-90% - Try suppressing ovarian function for 6 months - COCP, danazol, oral or depot progesterone, IUS - NSAIDs for pain - or GnRH analogues with add back therapy Surgery - Laparoscopic excision or ablalation - Endomeriomata (large cysts from endometriosis) need stripping out - Hysterectomy as last resort
276
Complications of endometriosis
Increased breast and ovarian cancers Infertility due to tubal damage Adhesions post-op Increased IBD
277
Pathophysiology of atrophic vaginitis
Decreased oestrogen Vaginal mucosa thins, drier, decreased elasticity Can become inflamed and lead to urinary symptoms Changes in vaginal pH and flora can predispose to UTIs
278
Aetiology of atrophic vaginitis
``` Natural menopause or oophorectomy Anti-oestrogen treatments: tamoxifen. aromatase inhibitors Radiotherapy Chemotherapy Post partum Breastfeeding ```
279
Presentation of atrophic vaginitis
``` Vaginal dryness Burning/itching of vagina or vulva Dyspareuunia Vaginal discharge (white/yellow) Vaginal bleeding Post coital bleeding Urinary symptoms: frequency, nocturia, dysuria, recurrent UTI, stress incontinence ``` ``` Decreased pubic hair Narrow introitus Thin mucosa Diffuse erythema Dryness Lack of vaginal folds ```
280
Investigations for atrophic vaginitis
Exclude other causes of PCB/infection/UTI Vaginal pH testing - alkaline Vaginal cytology - lack of maturation of vaginal epithelium Often a clinical diagnosis
281
Management of atrophic vaginitis
Lubricants - short term relief Water or silicone based Moisturisers - regular use Hormonal treatments: - HRT topical Restores pH, thickens epithelium, improves lubrication Very effective in long term, minimal side effects
282
Define menopause
12 months of spontaneous amenorrhoea | Early menopause is between 40-45
283
Symptoms of menopause
``` Menstrual irregularity Hot flushes - head, face, neck, chest Sweats Urogenital symptoms - dyspareunia, vaginal discomfort, dryness, recurrent UTI, incontinence Sleep disturbance Mood changes - anxiety, nervousness, irritability Loss of libido Brittle nails, thinning skin, hair loss ```
284
Investigations for menopause
Generally clinical Lab requirements only if under 45 Raised FSH Check TFTs Blood glucose cholesterol Check up to date with cervical and breast screening
285
Define premature ovarian failure
Amennorhoea Raised gonadatrophins Oestrogen deficienct Women under 40
286
Aetiology for ovarian failure
Decreased ovarian follicles at birth, accelerated follicle atresia or follicular dysfunction Mutations in FSH receptor Iatrogenic - surgery, radio or chemotherapy X linked chromosomal abnormality - Turners Autoimmune lymphocytic oophritis Infections - mumps, TB, malaria, chicken pox, CMV
287
Investigations for premature ovarian failure
Raised FSH - on 2 occasions, 4 weeks apart Decreased oestrodiol TFTs and prolactin DEXA scan Anti-Mullerian hormone as a measure of decreased ovarian reserve Test - adrenal antibodies, autoimmune, hypothyroid, diabetes, addison's
288
Management of premature ovarian failure
Manage depression and anxiety Lifestyle advice to decrease CV risk Adequate vitamin D and calcium HRT until 51 (no risks of HRT as under 50s)
289
Benefits of HRT
``` Decreased vasomotor symptoms in 4 weeks Increased quality of life Increased sleep Increased mood Decreased vaginal atrophy Decreased osteoporosis risk Decreased CV disease (doesn't increase if started under 60) Decreased colorectal risk Decreased aging ```
290
Risks of HRT
``` VTE PE Stroke Breast and endometrial cancer (If BMI normal) Gallbladder disease ```
291
Side effects of HRT
``` Breast tenderness Leg cramps Bloating Nausea Headache PMS Backache Depression Pelvic pain ```
292
Prescribing HRT
``` Check personal and FHx of VTE Confirm no sinister pathology No maximal duration Transdermal has fewer risks Continuous combined Erratic bleeding common for first 3-6 months ```
293
Ovarian cycles of menstruation
Follicular phase - follicles are stimulated due to rise of FSH Ovulation - ovarian follicles mature, egg released, rise in oestrogen causes rise of LH. LH surge causes release of egg Luteal phase - corpus luteum forms and produces progesterone which causes decrease in FSH and LH. When corpus luteum dies, decrease in progesterone which causes menstruation
294
Describe changes of LH and FSH in menstruation
LH remains at baseline until day 12-14 where there is very large LH surge There is a corresponding increase in FSH during this period but much lower than LH
295
Describe levels of oestrogen and progesterone in menstruation
oestrogen peaks just before ovulation | progesterone is low until after ovulation at which is steadily rises before dropping just before mensturation
296
Pathogenesis of dysmenorrhoea
Thought to be due to excess or imbalance of prostaglandins and leukotrienes in the menstrual fluid Causes vasoconstriction in uterine vessels Causes uterine contractions and pain
297
Define dysmenorrhoea
Low anterior pelvic pain which occurs in association with menstruation
298
Types of dysmenorrhoea
Primary - Occurs in young females with no pelvic pathology - Often begins 6-12 months after menarche - Pain begins with onset of period and lasts for 24-72 hours Secondary - Occurs in association of pelvic pathology - Can precede period by several days and last for the whole period - May be associated with dyspareunia
299
Aetiology of dysmenorrhoea
``` Endometriosis Adenomyosis PID Fibroids Adhesions Developmental abnormalities IUD ```
300
Adenomyosis
Invasion of myometrium with endometrial tissue Causes inflammation, pain and adhesions Chronic pelvic pain, dyspareunia and infertility
301
Epidemiology of dysmenorrhoea
Very common, incidence unknown RFs - Longer duration of periods - Early menarche - Smoking - Alcohol - Obesity - Depression Severity decreases with age Incidence decreases with childbirth
302
Presentation of dysmenorrhoea
Pain is usually suprapubic, but may be felt in the lower back/ back of legs May have pathological features: discharge, IMB or PCB, dyspareunia Dyschezia/rectal pain - endometriosis Hx features - age at menarche, cycle length, regularity, duration of period, timing of pain, smoking, sexual activity, obstetric and contraceptive history
303
Investigations for dysmenorrhoea
``` Speculum High vaginal swab/chlamydia screen Smear (if due) Pelvic US/TV US MRI Laparoscopy ```
304
Management of dysmenorrhoea
``` Lifestyle - smoking cessation TENS and locally applied heat NSAIDs - all are equally effective COCP POP Depo-medroxyprogesterone The above only if not trying to conceive ``` If trying to conceive then Danazol (only under specialist) Surgery - laparoscopic uterine nerve ablation or hysterectomy (only in refractory)
305
Aetiology of acute pelvic pain
``` UTI Miscarriage Ectopic pregnancy Torsion or rupture of ovarian cysts PID In late pregnancy - premature labour, placental abruption, uterine rupture Ovulation Dysmenorrhoea Degeneration of fibroid Pelvic tumour Pelvic vein thrombosis ``` Appendicitis, IBS, adhesions, prostatitis, strangulated hernia
306
Pelvic vein thrombosis
Associated post partum or in malignancy Pelvic pain Fever Abdominal mass
307
Investigations in acute pelvic pain
``` Urinalysis MSU High vaginal swab and endocervical swab Pregnancy test FBC Urgent US - if ?ectopic or miscarriage Laparoscopy (if severe) ```
308
Define chronic pelvic pain
Intermittent or constant pain in lower abdomen for >6 months. Does not occur exclusively with menstruation or sex Not associated with pregnancy
309
Aetiology of chronic pelvic pain
``` Endometriosis Adhesions IBS Interstitial cystitis MSK Pelvic organ prolapse Nerve entrapment Psychological and social issues - depression, physical or sexual abuse as children ```
310
Red flags for chronic pelvic pain
``` Rectal bleeding New bowel symptoms in over 50s New pain after menopause Pelvic mass Suicidal ideation Excessive weight loss Irregular vaginal bleeding in over 40s PCB ```
311
Investigations for chronic pelvic pain
``` STI screen] FBC, CRP CA125 if ?ovarian Ca (new IBS >50 is suspicious) Urinalysis and MSU TV US MRI if ?adenomyosis Diagnostic laparoscopy is gold standard ```
312
Management of chronic pelvic pain
Treat cause and psychological causes Challenging as pain often continues after treatment without diagnosis Treat underlying disorder Most managed in primary care If cyclical pain can use COCP or GnRH agonists or mirena
313
Types of benign ovarian tumours
Functional (24%) Benign (70%) Malignant (6%) Benign epithelial neoplastic cysts (60%) - Serous cystadenoma (40-50 years, papillary growths can appear solid, 20% malignant) - Mucinous cystadenoma (20-40 years - filled with mucinous material, become enormous, 5% malignant) Benign neoplastic cystic tumours of germ cell origin - Benign cystic teratoma (rarely malignancy, may contain well differentiated tissue, common in young women) Benign neoplastic solid tumours - Fibroma (<1% malignant, small solid, benign fibrous tumours - associated with Meig's syndrome and ascitets) - Thecoma - Adenofibroma - Brenner's tumour
314
Epidemiology of benign ovarian tumours
30% of females with regular periods 50% of females with irregular periods Occur in premenopausal women Uncommon pre-menarche and post-menopausal RF - Obesity - Tamoxifen - Early menarche - Infertility - Dermoid can run in families
315
Presentation of benign ovarian tumours
Asymptomatic Dull ache or pain in lower abdomen/back If rupture/torsion - severe abdominal pain and fever Dyspareunia Swollen abdomen, palpable mass Pressure effects - urinary frequent, peripheral oedema Torsion - severe pain, can be intermittent Rupture - peritonitis, shock, mucinous cystadeomas can continue to secrete mucin causing build up and death (psudomyxoma peritonei) Ascites
316
Meig's syndrome
Ascites Pleural effusion Benign ovarian tumour (fibroma, fibrothecoma, Brenner tumour)
317
Investigations for benign ovarian tumour
``` Pregnancy test FBC - infection, haemorrhage Urinalysis TV US CT or MIR if US inconclusive Diagnostic laparoscopy CA125 (do not do if premenopausal with cyst on US) - it is not reliable in distinguishing malignant/benign in fertile women LDH, AFP, beta - HCG for germ cell tumours ```
318
Risk of malignancy index
For suspected ovarian cancer Not to be used pre-menopausally Uses CA125, menopausal status and US score RMI = U x M x Ca125 US - 1 point each for: multilocular cysts, solid area, mets, ascites, bilateral lesions RMI > 200 = CT abdo pelvis
319
Management of benign ovarian tumours
<50mm, expectant management 50-70mm = yearly US follow up >70mm = MRI/surgery Do not use COCP Laparoscopic removal If torsion may need oophorectomy and uncoiling Immediate surgery if haemorrhagic - more common in R ovary
320
Epidemiology of dyspareunia
More common in women 9% of all women Increase in 20s-30s and over 60s RFs - Sexually inexperienced - peri or post-menopausal
321
Presentation of dyspareunia
Superficial (felt at introits) OR deep (felt with thrusting and deep in pelvis) tightening of vaginal muscles on penetration - vaginismus When/where/duration Is intercourse possible? Desired? Any evidence of sexual abuse, rape or trauma Any FGM STI risk
322
Aetiology of dyspareunia
Pain with arousal - Hymenal ring bands - Swelling of Bartholin's gland cyst Sensitive external genetalia - Vulvodynia - Chronic vulvitis - allergy, candida, herpes, trichomonas - Lichen planus/sclerosis Pain at introitus on penetration - Painful episiotomy scar - rigidity of hymenal ring - Inadequate lubrication - atrophic vaginitis - vaginitis - vaginismus - insufficient foreplay - congenital abnormality Mid vaginal pain - Acute/chronic cystitis - Urethritis - Shortened vagina Deep pain - PID - Vaginiits - Cervicitis - Malposition of IUS/IUD - Endometrisosis/adenomysosis - Fibroids - Fixed retroverted uterus - IBS - IBD - Pelvic mass - Interstitial cystitis
323
Investigations for dyspareunia
Swab for STIs Urine dip &; MSU US
324
Types of incontinence
``` Functional Stress Urge Mixed Overactive bladder syndrome Overflow True ```
325
Functional incontinence
Patient is unable to reach the toilet in time e.g. poor mobility or unfamiliar surroundings
326
Stress incontinence
Involuntary leakage of urine on effort or exertion e.g. sneezing or coughing. Due to incompetent sphincter May be associated with GU prolapse
327
Urge incontinence
Involuntary urine leakage accompanied or preceded by urgency of micturition Detrusor instability or hyper-reflexia leading to involuntary detrusor contraction Idiopathic or neurological
328
Mixed incontinence
Involuntary leakage associated with both urgency and exertion
329
Overactive bladder syndrome
Urgency that occurs with or without urge incontinence and usually with frequency and nocturia
330
Overflow incontinence
Usually due to chronic bladder outflow obstruction e.g. prostatic disease Can cause obstructive nephropathy
331
True incontinence
Fistulous track between vagina and ureter or bladder and urethra. Continuous urine leakage
332
Epidemiology of incontinence
``` Very common ~ 8%, up to 40% Increase in females Most common = stress incontinence Increases with age Increased if in institution ``` RFs - Pregnancy, vaginal delivery especially with forceps - Diabetes - Oral oestrogen therapy - Raised BMI - Hysterectomy (RF for stress) - Increased parity (RF for stress) - Frequent UTIs - Neurological disease - stroke, dementia, Parkinson's - Cognitive impairment
333
History features of incontinence
Leakage on sneezing, coughing, exercise, standing Urgency LUTS - dribbling, frequency, dysuria, incomplete emptying Sexual dysfunction Full obstetric history Bladder chart
334
Investigations for incontinence
Urine dipstick + MSU Assessment of residual volume (bladder scan for post-void volume) Urinary flow rates Urodynamic studies Refer - any haematuria - prolapse below introitus - neurological disease - persisting pain - faecal incontinence
335
Management of incontinence
Temporary containment products only until specific diagnosis and management plan. STRESS - Pelvic floor exercises for 3 months, 8 contractions TDA - Duloxetine - Retopubic mid-urethral tape - Colopsuspension - Autologous rectal fascial sling MIXED - pelvic floor exercises and bladder taining - Oxybutinin (anitmuscarinic) - Annual review OVERFLOW - relieve obstruction - intermittent self-catheterisation if persistent retention - botulinum toxin A - desmopressin if troublesome nocturia
336
Define overactive bladder
Urgency Often with frequency Nocturia Sometimes urge incontinence Often associated with detrusor muscle over activity
337
Epidemiology of overactive bladder
2nd most common cause of female urinary incontinence Increases with age Associated with Parkinson's, spinal cord injury, diabetic neuropathy, MS, dementia, stroke
338
Presentation of overactive bladder
``` Sudden urge to urinate Hard to delay Frequency of micturition Nocturia Abdominal discomfort Urge incontinence ```
339
Management of overactive bladder
Lifestyle - decrease caffeine, increase fluid intake, lose weight if BMI > 30 Bladder tainting - 1st line, minimum of 6 weeks. Scheduled voiding, regular intervals, increasing time intervals Drugs - anticholinergics (oxybutynin, propiverine) Decreases involuntary contractions to increase bladder capacity Intravaginal oestrogens in vaginal atrophy Botulinum A toxin Nerve stimulation - sacral nerve Surgery - only for severe
340
Epidemiology of faecal incontinence
Increased in women 3 per 100,000 Increases with age ``` RFs diarrhoea anal problems - obstetric injury, rectal or pelvic organ prolapse, pelvic radiotherapy Urinary incontinence Frail elderly patients Neuro problems/spinal disease Vaginal delivery Severe cognitive impairment ```
341
Aetiology of faecal incontinence
``` Child birth Obstetric trauma Anal surgery Chronic anal fissure Degeneration of smooth muscle in internal anal sphincter Neurological disease Dementia Congenital disorders - Hirschprung's, spina bifida Constipation Rectal prolapse IBD ```
342
Management of faecal incontinence
``` Treat underlying cause Diet Encourage bowel opening after a meal Sitting or squatting to avoid straining Antidiarrhoeal medications - loperamide or codeine ``` Continence produces Skin care Odour control If faecal loading - clear bowel Pelvic floor training Bowel retraining Electrical stimulation Rectal irrigation
343
Physiology of micturition
Pudendal nerve is under our control - when activated causes contraction of external sphincter to contract ``` Hypogastric nerve (sympathetics) - NA causes contraction of external sphincter ``` Sympathetics cause urinary retention Parasympathetic causes voiding Parasympathetic pelvic nerve causes detrusor contraction Empty bladder - no stretching - slow impulse along sensory pelvic nerve - this activates hypogastric nerve - causes relaxation of detrusor Full bladder - stretching - increasing fast signals to sacral region - bypass straight to pontine micturition centre - inhibits sympathetics (hypogastric nerve) - Relaxation of external sphincter - contracts detrusor
344
Where in brainstem is micturition centre?
pons
345
Aetiology of vaginal discharge
``` Physiological - New born infants - from maternal oestrogens - Reproductive age: normal Low oestrogen = mucus thick and sticky High oestrogen = mucus clearer, wetter - Cervical ectopy and polyps - Foreign bodies e.g. retained tampon - Vulval dermatitis - Erosive lichen planus - Genital tract malignancy - Fistulae ``` Infection - BV - Thrush. Candidiasis - Chlamydia trachomatis - Neisseria gonorrhoea - Trichomonas vaginalis
346
Presentation of vaginal discharge
BV - thin, profuse, fishy smelling. No soreness, no itch. Candidiasis - thick, curd like, white, non-offensive. Vulval itch, soreness. Mild dyspareunia and dysuria. Chlamydia - copious purulent discharge. Asymptomatic in 80% Trichomonas - offensive, yellow discharge. profuse and frothy. Vulval itch, soreness, dysuria, abdo pain, superficial dyspareunia Gonorrhoea - purulent vaginal discharge. asymptomatic in 50% Retained foreign body - foul smelling seroanguinous discharge Fistulae - foul or faeculent discharge
347
Signs vaginal discharge is abnormal
``` Discharge heavier than normal Discharge thicker than normal Pus like discharge White and clumpy discharge Grey/green/yellow/blood tinged Foul smelling Accompanied by itching, burning, rash or soreness ```
348
Causes of vaginal discharge in pregnancy and consequences
BV - poor perinatal outcomes Candida - No harm to foetus Chlamydia - doesn't affect pregnancy outcome but mother baby transmission can occur - opthlamia neonatorum 15-25% - pneumonitis 5-15%
349
Investigations for vaginal discharge
If typical BV or candidia, can be treated without testing STI screening and swabs - Vulvovaginal/ endocervical swabs - Urine chlamydia testing - Blood tests for HIV and syphilis Vaginal pH testing - BV pH>4.5
350
Epidemiology of bacterial vaginosis
5-12% of normal population 30% undergoing termination of pregnancy Increased in sexually active women RFs - Sexual activity - New sexual partner - Other STIs - Increased in Afro-Caribbean - IUCD (copper) - Vaginal douching - Bubble baths - Receptive oral sex - Smoking Protective - COCP - Condoms - Circumcised partner
351
Aetiology of bacterial vaginosis
Overgrowth of anaerobic organisms Most common - Gardnerella vaginalis, prevotella, mycoplasma hominis, mobiluncus They replace the lactobacilli Raised pH from 4.5 to 6 (becomes alkaline)
352
Presentation of bacterial vaginosis
Offensive, fishy smelly discharge No soreness or irritation 50% are asymptomatic Thin wall of white discharge on vaginal walls
353
Investigations for bacterial vaginosis
Amsel's criteria (3+ of) - Homogenous offensive discharge - Microscopy - large numbers of bacilli "clue cells" on vaginal epithelial cells - pH>4.5 - Fishy odour on adding 10% potassium hydroxide - Cannot use isolation of G. vaginalis as it is normal flora in 40% Often treated empirically Examine and swab Vaginal pH
354
management of bacterial vaginosis
Avoid vaginal douching Avoid shower gel and bubble bath Do not need treatment if asymptomatic Oral metronidazole +/- clindamycin
355
Complications of bacterial vaginosis
Endometritis and PID Increased risk of acquiring HIV and STIs Late miscarriage, pre-term delivery, PROM, decreased birth weight 70% relapse in 3 months
356
Chlamydia
Small, obligate, intracellular Gram negative Infected columnar and transitional epithelium Can cause - Ocular infections - GU infections - Proctitis - Sexually acquired reactive arthritis - Lymphgranuloma venerum - STI tropical infection, genital ulcer and inguinal lymphadenopathy
357
Epidemiology of GU chlamydia
Most common STI in UK Most common preventable cause of infertility worldwide Prevalence dependent on age Increased in under 25s Decreasing numbers presenting to screening RFs - Age < 25 - Sexual partner chlamydia positive - 2+ sexual partners in 1 year - Recent change in sexual partner - Non barrier contraception - Infection with another STI - decreased socio-economic status
358
Presentation of chlamydia infection
Most cases are asymptomatic Female - Vaginal discharge - Dysuria (sterile pyuria) - Lower abdominal pain - Fever - IMB, PCB - Deep dyspareunia Male - Urethritis - Dysuria - Urthethral discharge - Epididymo-orchiditis - Fever Reiter's syndrome - urethritis, arthritis, conjunctivitis. Associated with HLAB27 Proctitis with mucopurulent discharge if anal chlamydia
359
Signs of chlamydia infection
Female - Friable, inflamed cervix - Mucopurulent discharge - abdominal tenderness - adnexal tenderness - cervical excitation Males - epididymal tenderness - mucopurulent discharge - perineal fullness
360
Investigations for chlamydia
Samples for nucleic acid amplification tests (NAATs) Vulvovaginal swabs Can do endocervical swab or first catch urine Opportunistic screening at GP Test when - Symptoms suggest infection - Sexual partners of chlamydia positive patients - All sexually active under 25 annually or with change of partner - Termination of pregnancy - At GUM clinic
361
Management of chlamydia
Antibiotics - doxyxyxline 100mg BD 7/7 or azithromycin 1g stat Screen for other STIs Partner notification - If asymptomatic: back to 6m - If symptomatic 4/52 before symptoms No need to retest after treatment unless pregnant, persistent symptoms, non-compliant or re-exposed
362
Complications of chlamydia infection
``` PID Female infertility Ectopic pregnancy Perihepatitis (Fitz-Hugh and Curtis syndrome) Reactive arthritis (Reiter's syndrome) ```
363
Gonorrhoea
Gram negative diplococcus Infects mucus membranes Transmission via direct inoculation of infected secretions - sexually or perinatally
364
Epidemiology of gonorrhoea
Increasing prevalence Most causes in homosexual men Most diagnosed in GUM clinics Increased in younger ages RFs - History of previous STI - Co-existent STIs - New or multiple sexual partners - Recent sexual activity abroad - Inconsistent condom use - Anal intercourse and frequent insertive oral sex - Drug use or commercial sex work
365
Presentation of gonorrhoea
Symptomatic in most men (90-95%) Asymptomatic in 50% of women Male - urethral discharge - dysuria - rectal infection (anal discharge) - pruritus - urthethral discharge Female - discharge - abdominal pain - dysuria - rare cause of IMB - pelvic tenderness - mucopurulent discharge
366
Investigations for gonorrhoea
Culture - for resistant strains NAAT - urine or urthethral swabs Vulvovaginal swab is superior in women
367
Management of gonorrhoea
Check for other STIs Partner notification Ceftriaxone 500mg IM stat + azithromycin 1g stat Resistance is an ongoing issue
368
Complications of gonorrhoea
male - urethral scarring and stricture (BOO), acute epididymitis, prostatitis, peri-urethral abscess ``` Female PID Infetrilty Peri-hepatitis (Fitz-Hugh Curtis syndrome) Bartholin's abscess Ectopic pregnancy Premature labour miscarriage ``` Can have haematogenous dissemination <1% Skin lesions, Reiter's syndrome, arthralgia, meningitis, endocarditis
369
Trichomonas vaginalis
``` Flagellated protozoan Most curable STI worldwide Urethral infection in 90% Most are women Underdiagnosed and undertreated ```
370
Presentation of trichomonas vaginalis
FEMALE - vaginal discharge, frothy and yellow - Vulval itching - dysuria - offensive odour - lower abdominal discomfort - cervicitis - 10-50% have no symptoms - 5-15% have normal exam MALE - usually asymptomatic - dysuria - urethral discharge - most have no signs
371
Investigations for trichomonas vaginalis
``` High vaginal swab Refer to GUM clinic Wet microscopy Test for other STIs Urethral culture or urine culture NAATs are being gold standard ```
372
Management of trichomonas vaginalis
Treat both partners at the same time Avoid sex 7/7 post-treatment Metronidazole 2g stat
373
Complications of trichomonas vaginalis
``` Pre term delivery Low birth weight Increased maternal post partum sepsis Prostatis in men Persistent and recurrent infections ```
374
Epidemiology of HIV
``` 6000 new UK diagnoses per year Increased in males Increased in men who have sex with men (MSM) Increased in Blacks Increased if born abroad ```
375
Stages of HIV infection
``` Seroconversion illness Asymptomatic infection Persistent generalised lymphadenopathy Symptomatic infection AIDS ```
376
Seroconversion illness in HIV
``` 1-6 weeks post infection 20-60% present at this time Glandular fever like illness Fever, malaise, myalgia, headaches, diarrhoea, lymphadenopathy, maculopapular rash Viral p24 antigen positive High HIV RNA levels Antibody tests negative ```
377
Persistent generalised lymphadenopathy in HIV
Nodes>1cm in diameter at 2 extra inguinal sites | Persists for longer than 3 months
378
Symptomatic HIV infection
Non specific constitutional symptoms - fever, night sweats, diarrhoea, weight loss Minor opportunistic infections: oral candida, herpes zoster, recurrent herpes simplex, seborrheic dermatitis - Prodrome to AIDS
379
Investigations for HIV
anti-HIV IgG antibody tests (not reliable in under 18m old) HIV DNA PCR and virus culture In acute infection will be p24 positive IgG and IgM to HIV 4 weeks to get test results back HIV counselling before and after testing
380
Staging of HIV
CD4 grade 1. CD4 > 500 cells/mm3 or 29% 2. CD4 200-499 cells/mm3 or 14-28% 3. CD4<200 cells/mm3 or <14% Clinical grade A. Documented HIV infection. Asymptomatic or persistent lymphadenopathy B.. Symptomatic but no category C conditions C. AIDs indicator condition. Cannot move out of category C Receive both clinical and CD4 grading Clinical Grade
381
AIDS defining conditions
``` Candidiasis - lung/trachea/oesophagus Invasive cervical carcinoma Coccidiodomycosis. Crytococcosis. CMV (not liver or spleen) Encephalopathy Herpes simplex Histoplasmosis Kaposi's sarcoma Lymphoma - Burkitt's, primary brain or immunoblastic TB Pneumocystis jirovecci Recurrent pneumonia Progressive multifocal leukoencephalopathy Toxoplasmosis of brain Wasting syndrome due to HIV ```
382
Management of HIV
Support Anti retroviral therapy for all patients HAART - combination of 3 drugs to decrease resistance Efaurenz + tenofovir + lamivudine Chemoprophylaxis to prevent infection
383
Preventing spread of HIV
``` Promote lifelong safer sex Barrier contraception Decrease number of partners Condom program in brothels Warn heterosexuals the dangers of sex tourism Treat other STIs Don't share needle - needle exchange programs Decrease unnecessary blood transfusions Encourage HIV tests in pregnancy Pre-exposure prophylaxis in high risk ```
384
Karposi's sarcoma
Multiple echhymotic skin nodules, macules or papules. Skin or mucosal surfaces Can have visceral disease e.g. lungs and GIT
385
HIV encephalopathy
``` Brain involved in most late HIV Decreased concentration and memory Gradual decrease in intellect Increased motor problems and weakness Hyper-reflexia Extensor plantars ```
386
Aetiology of anogenital warts
HPV infection Sexually transmitted 60% transmission rate between partners 95% caused by HPV 6 or 11
387
Epidemiology of anogenital warts
Most common viral STI Numbers should decrease with HPV vaccination 35% of those being screened for chlamydia ``` RF Smoking Multiple sexual partners Early age of first intercourse History of other STIs Anoreceptive intercourse Immunosuppression ```
388
Symptoms of anogenital warts
Painless lesions Can be disfiguring or embarrassing Can cause itching, bleeding or dyspareunia Urethral lesions may distort urinary stream Pelvic or scrotal pain
389
Signs of anogenital warts
``` Often multiple lesions Can become confluent (huge in immunocompromised) Can be keratinsed or non-keratinised May be broad based or pedunculated may be pigmented ``` In women on: labia, clitoris, urethral meaturs, introitus, vagina or cervix Men - frenulum, corona, glans penis, shaft, scrotum, urethral meatus both - perineum, groin, pubic, perianal area, anal canal
390
Investigations for anogenital warts
Biopsy and viral typing not usually required | Only biopsy if anything suspicious e.g. over 35 with minimal risk factors
391
Diseases associated with anogenital warts
cervical cancer Vaginal, penile and vulval cancer Anal cancer Oral and oropharyngeal cancer
392
Management of anogenital wards
Explain long term latency - does not mean infidelity Advise condom use until resolved Advise HPV persists long after warts 20% have concurrent STIs = SCREEN Assess current and past partners - last 6 months Non-smokers have better response to treatment No treatment, 1/3 regress spontaneously in 6 months Podaphylotoxin cream or imiquimod 5% Can use ablation. cryotherapy or excision if resistant Treatments cause itching, burning, pain. Recurrence occurs after all treatmetns.
393
Herpes Simplex
HSV Type 1- usual cause of cold sores. Now most common cause of genital herpes HSV type 2 - causes genital infection. transmission: Contact with infected secretion Close contact Vaginal, anal and oral sex
394
Cause of genital herpes
Herpes simplex - type 1 and 2
395
Epidemiology of herpes simplex
``` 7% of new STIs Numbers are increasing Highest in 15-24s Lifelong disease 80% are not aware they have it 20% of population ``` ``` Rf Sexual promiscuity Previous history of STIs Early age of first intercourse MSM HIV infection Females ```
396
Presentation of herpes simplex
``` Primary infection Commonly asymptomatic Febrile flu like prodrome 5-7 days Myalgia. Fever Tingling neuropathic pain in genital area Extensive painful crops of blisters/ulcers in genital area Usually bilateral Tender inguinal lymph nodes Dysuria/ Vaginal or urethral discharge ``` ``` Secondary infection After latency, reactivation Episodes are shorter e.g. 10 days Mild and self-limiting Lesions unilateral ``` HSV type 1 less recurrence (1/year) 2 = 4 per year
397
Investigations for herpes simplex
Viral culture DNA detection using PCRR Serology testing - takes 12 weeks
398
Management of herpes simplex
Refer to GUM clinic Swab Supportive management Saline bathing Oral analgesia Topical lidocaine Micturation sitting in bath to prevent urinary retention Increase fluid intake to dilute urine to decrease pain Antivirals not recommended unless within 5 days, aciclovir
399
Complications of herpes simplex infection
``` Autonomic neuropathy e.g. urinary retention aseptic meningitis Spread to extra-genital areas 2y infection with candida or strep Perinatal transmission psychological or psychosexual problems ```